You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selective serotonin re-uptake inhibitor (SSRI)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Social Phobia Trial in Hamilton (Topiramate, Placebo)

Terminated
  • Social Phobia
  • Hamilton, Ontario, Canada
    MacAnxiety Research Centre
Aug 31, 2020

Haemorrhage Between Vortioxetine Tablet Treatment and Selective

Not yet recruiting
  • Major Depressive Disorder
  • Vortioxetine Tablet
  • SSRI
  • (no location specified)
Jun 28, 2023

Major Depressive Disorder With Anhedonia and Inadequate Response

Not yet recruiting
  • Depressive Disorder, Major
  • No Intervention
  • (no location specified)
Apr 24, 2023

Depression Trial in Atlanta (drug, behavioral, other)

Completed
Has Results
  • Depression
  • Selective serotonin re-uptake inhibitor
  • +2 more
  • Atlanta, Georgia
    12 Executive Park Drive, 3rd floor
Oct 13, 2020

Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • aiTBS
  • +2 more
  • Ghent, East-Flanders, Belgium
    University Hospital Ghent
Dec 6, 2022

SSRI's and the Rate of Progression From MCI to Dementia

Recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Columbus, Ohio
    The Ohio State University
Sep 8, 2021

Risk Factors for AD-Associated Switch to Mania

Completed
  • Bipolar Disorder
  • Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
  • Barcelona, Catalonia, Spain
    Hospital Clinic Barcelona
Nov 17, 2021

PTSD Trial in Boston (LDAEP, Placebo, sertraline)

Recruiting
  • Posttraumatic Stress Disorder
  • LDAEP
  • +2 more
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 9, 2022

Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

Completed
Has Results
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +49 more
Jul 20, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • San Diego, California
  • +26 more
Aug 17, 2022

Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Completed
  • Depressive Disorder, Major
  • Esketamine 28 mg
  • +6 more
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +170 more
Sep 13, 2022

Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

Not yet recruiting
  • Depression
  • Serotonin Deficiency
  • Pharmacological agent: Citalopram
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan Campus
Jul 19, 2023

Stroke Trial in Bordeaux, Toulouse (Fluoxetine, Placebo, fMRI)

Unknown status
  • Stroke
  • Bordeaux, France
  • +1 more
Jul 29, 2020

Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

Active, not recruiting
  • Depressive Disorder, Major
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +58 more
Jan 31, 2023

DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

Not yet recruiting
  • Parkinson Disease
  • scintigraphy DaTSCAN
  • Vandœuvre-lès-Nancy, France
    CHRU Nancy
Jan 5, 2023

Post-Traumatic Stress Disorder Trial (Nabiximols, Placebo)

Withdrawn
  • Post-Traumatic Stress Disorder
  • (no location specified)
Jun 2, 2022

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Birmingham, Alabama
  • +156 more
Jan 31, 2023

Depression, Amyotrophic Lateral Sclerosis Trial in Saint Louis (Tricyclic Antidepressants ("TCA"), Selective Serotonin Uptake

Completed
  • Depression
  • Amyotrophic Lateral Sclerosis
  • Tricyclic Antidepressants ("TCA")
  • Selective Serotonin Uptake Inhibitors ("SSRI")
  • Saint Louis, Missouri
    Monteleone Hall, Saint Louis University, 1438 South Grand Blvd.
Jan 13, 2020

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticrapant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Phoenix, Arizona
  • +72 more
Jul 10, 2022

Peri-implantitis and Assumptions of Medications

Completed
  • Peri-Implantitis
  • Dental implants
  • Milan, Italy
    IRCCS Istituto Ortopedico Galeazzi
May 15, 2022

MDD Trial in Ballarat, Clayton, Melbourne (Participants will be prescribed an approved selective serotonin re-uptake inhibitor

Unknown status
  • Major Depressive Disorder
  • Participants will be prescribed an approved selective serotonin re-uptake inhibitor (SSRI) antidepressant.
  • Ballarat, Victoria, Australia
  • +3 more
Nov 1, 2018

MDD, Recurrent, Unspecified, MDD, Single Episode, Unspecified Trial in Worldwide (H-Coil Deep TMS in combination with SSRIs)

Completed
  • Major Depressive Disorder, Recurrent, Unspecified
  • Major Depressive Disorder, Single Episode, Unspecified
  • H-Coil Deep TMS in combination with SSRIs
  • Davis, California
  • +18 more
Jul 13, 2020

MDD Trial in Manchester, Liverpool (SPL026)

Recruiting
  • Major Depressive Disorder
  • Manchester, Greater Manchester, United Kingdom
  • +1 more
Jan 18, 2023

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

Depressive Disorder, Anxiety Trial in Worldwide (JNJ-42165279, Placebo)

Completed
Has Results
  • Depressive Disorder
  • Anxiety
  • Costa Mesa, California
  • +31 more
Nov 9, 2022